Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hemodynamic-dependent patterning of endothelin converting enzyme 1 expression and differentiation of impulse-conducting Purkinje fibers in the embryonic heart.
Hall CE, Hurtado R, Hewett KW, Shulimovich M, Poma CP, Reckova M, Justus C, Pennisi DJ, Tobita K, Sedmera D, Gourdie RG, Mikawa T. Hall CE, et al. Among authors: reckova m. Development. 2004 Feb;131(3):581-92. doi: 10.1242/dev.00947. Epub 2004 Jan 7. Development. 2004. PMID: 14711873 Free article.
Optical mapping of electrical activation in the developing heart.
Sedmera D, Reckova M, Rosengarten C, Torres MI, Gourdie RG, Thompson RP. Sedmera D, et al. Among authors: reckova m. Microsc Microanal. 2005 Jun;11(3):209-15. doi: 10.1017/S1431927605050452. Microsc Microanal. 2005. PMID: 16060973
The oldest, toughest cells in the heart.
Thompson RP, Reckova M, deAlmeida A, Bigelow MR, Stanley CP, Spruill JB, Trusk TT, Sedmera D. Thompson RP, et al. Among authors: reckova m. Novartis Found Symp. 2003;250:157-74; discussion 174-6, 276-9. Novartis Found Symp. 2003. PMID: 12956329 Review.
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.
Fizazi K, Le Teuff G, Fléchon A, Pagliaro L, Mardiak J, Geoffrois L, Laguerre B, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Cancel M, Juzyna B, Reckova M, Naoun N, Logothetis C, Culine S. Fizazi K, et al. Among authors: reckova m. J Clin Oncol. 2024 Aug 21:JCO2301960. doi: 10.1200/JCO.23.01960. Online ahead of print. J Clin Oncol. 2024. PMID: 39167741
The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group.
Mego M, Kasperova B, Chovanec J, Danis R, Reckova M, Bystricky B, Konkolovsky P, Jurisova S, Porsok S, Vaclav V, Wagnerova M, Stresko M, Brezinova B, Sutekova D, Ciernikova S, Svetlovska D, Drgona L. Mego M, et al. Among authors: reckova m. Front Oncol. 2024 Jul 22;14:1438657. doi: 10.3389/fonc.2024.1438657. eCollection 2024. Front Oncol. 2024. PMID: 39104721 Free PMC article.
Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.
Mego M, Danis R, Chovanec J, Jurisova S, Bystricky B, Porsok S, Konkolovsky P, Vaclav V, Wagnerova M, Streško M, Brezinova B, Rečková M, Sutekova D, Pazderova N, Novisedlakova M, Zomborska E, Ciernikova S, Svetlovska D, Drgona L. Mego M, et al. Among authors: reckova m. Front Oncol. 2023 Aug 4;13:1168654. doi: 10.3389/fonc.2023.1168654. eCollection 2023. Front Oncol. 2023. PMID: 37601667 Free PMC article.
36 results